{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:33:32Z","timestamp":1791221612404,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.cancergencyto.2009.10.004","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T10:11:56Z","timestamp":1264587116000},"page":"46-53","source":"Crossref","is-referenced-by-count":51,"title":["Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells"],"prefix":"10.1016","volume":"197","author":[{"given":"Xiaolei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.10.004_bib1","first-page":"945","article-title":"Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention","volume":"8","author":"Buettner","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(00)02430-3","article-title":"Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells","volume":"48","author":"Gao","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI0215617","article-title":"Stat proteins and oncogenesis","volume":"109","author":"Bromberg","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/gyno.2000.5931","article-title":"Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells","volume":"79","author":"Huang","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib6","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1038\/sj.onc.1204990","article-title":"Inhibition of constitutively active STAT3 suppresses growth of human ovarian and breast cancer cells","volume":"20","author":"Burke","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/cyto.2002.1022","article-title":"Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas","volume":"17","author":"Savarese","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib8","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1158\/0008-5472.CAN-03-3959","article-title":"Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility","volume":"64","author":"Silver","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib9","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1038\/sj.onc.1204086","article-title":"STAT proteins: novel molecular targets for cancer drug discovery","volume":"19","author":"Turkson","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib10","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1038\/sj.onc.1203476","article-title":"The role of STATs in transcriptional control and their impact on cellular function","volume":"19","author":"Bromberg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","article-title":"Cancer statistics. CA. Cancer","volume":"47","author":"Parker","year":"1997","journal-title":"J. Clin"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib12","first-page":"3351","article-title":"Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma","volume":"62","author":"Masuda","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib13","first-page":"1445","article-title":"Activation of STAT3 is a marker of poor prognosis in human colorectal cancer","volume":"15","author":"Kusaba","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/path.857","article-title":"P53 mutation does not affect prognosis in ovarian epithelial malignancies","volume":"194","author":"Fallows","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.phrs.2007.09.010","article-title":"Transfection of Smac\/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro","volume":"56","author":"Mao","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib16","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","article-title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer","volume":"66","author":"Kelly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib17","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-06-0861","article-title":"Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer","volume":"12","author":"Duan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib18","first-page":"1119","article-title":"Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells","volume":"28","author":"Zhou","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2362.2008.02070.x","article-title":"Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells","volume":"39","author":"Wang","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1022696012668","article-title":"(extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma","volume":"20","author":"Davidson","year":"2003","journal-title":"Clin Exp Metastas"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib21","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1073\/pnas.0534764100","article-title":"Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell grow","volume":"100","author":"Leong","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-2407-7-149","article-title":"Therapeutic effects of STAT3-decoy oligodeoxynucleotide on human lung cancer in xenograft mice","volume":"7","author":"Zhang","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1471-2407-9-233","article-title":"Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma","volume":"9","author":"Yeh","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib24","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/1078-0432.CCR-06-2313","article-title":"Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications","volume":"13","author":"Huang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.biocel.2008.09.018","article-title":"Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2\/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin","volume":"41","author":"Colomiere","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ijc.10390","article-title":"Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts","volume":"99","author":"Kanekura","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib28","doi-asserted-by":"crossref","first-page":"50326","DOI":"10.1074\/jbc.M207446200","article-title":"The matrix metalloproteinase 9 (MMP-9) hemopexin domain is a novel gelatin-binding domain and acts as an antagonist","volume":"277","author":"Roeb","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1067\/msy.2002.125353","article-title":"Fibroblasts promote breast cancer cell invasion by up-regulating tumor matrix metalloproteinase-9 production","volume":"132","author":"Wang","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib30","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0092-8674(86)90594-5","article-title":"Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins","volume":"47","author":"Gros","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib33","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M800109200","article-title":"Hyaluronan-CD44 Interaction Activates Stem Cell Marker, Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells","volume":"283","author":"Bourguignon","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000129389","article-title":"JAK\/STAT and PI3K\/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes","volume":"21","author":"Lu","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib36","doi-asserted-by":"crossref","first-page":"23432","DOI":"10.1074\/jbc.M302674200","article-title":"AKT2 inhibition of cisplatininduced JNK\/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance","volume":"278","author":"Yuan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2009.10.004_bib37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1124\/mol.106.024273","article-title":"Single decoy oligodeoxynucleotides targeting multiple oncoproteins produces strong anticancer effects","volume":"70","author":"Gao","year":"2006","journal-title":"Mol Pharmacol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809005937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809005937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T17:24:51Z","timestamp":1544721891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809005937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0165460809005937"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.10.004","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}